The MiStent Sirolimus eluting absorbable polymer coronary stent system (MiStent SES) optical coherence tomography (OCT) study has completed enrolment, according to a press release from Micell Technologies.
The US Food and Drug Administration has announced a proposal to ban most powdered gloves in the USA. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness or injury to health care providers, patients and other individuals who are exposed to them, which cannot be corrected through new or updated labelling, according to an FDA news release.
Sir Nilesh Samani has been announced as the next medical director of the British Heart Foundation (BHF). He will succeed Peter Weissberg who will retire in October 2016 after 12 years as medical director of the cardiovascular research charity.
The Xposition S (Stentys), a sirolimus-eluting self-apposing stent, has received CE marking for the treatment of unprotected left main coronary artery disease.
Lindsay Anderson (Duke Clinical Research Institute, Duke University Medical Center, Durham, USA) and others report in the American Heart Journal that, compared with medical management, percutaneous coronary intervention (PCI) is not associated with a significant reduction hospital readmission for syncope in older patients with syncope and obstructive coronary artery disease. However, it was associated with a significant reduction in mortality at three years.
A single-centre study, published in the American Journal of Cardiology, from The Children’s Hospital of Philadelphia (CHOP) indicates that as many as one in five adult patients with congenital heart disease have symptoms of post-traumatic stress disorder (PTSD), with about one in 10 patients having symptoms that are directly related to their heart condition. The study researchers suggest that clinicians and carers need to be aware of possible PTSD symptoms, such as anxiety and depression, in their patients.
According to CorMatrix, a patient has become the first person to receive the company’s tissue-engineered regenerative tricuspid valve. The operation was performed by Marc Gerdisch (Franciscan St Francis Health, Indianapolis, USA), who was implanting the valve as part of CorMatrix’s investigational device exemption (IDE)-feasibility study of the device. The aim of the FDA-approved trial is to demonstrate proof of principle and initial clinical safety of the CorMatrix ECM tricuspid valve.
Opsens has received 510(k) clearance from the FDA for OptoWire II—an optical guidewire developed to measure fractional flow reserve (FFR). The company has already received FDA clearance to sell the OptoWire I, the first generation of its optical guidewire. This latest approval allows Opsens to
The first implantation of BioVentrix’ micro-anchor technology entirely within the left ventricle using a catheter-based endovascular approach has been successfully completed.
Medinol continued its introduction of its novel stent solutions during the 2015 Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco.
Happiness itself has no direct effect on mortality, according to a study published in The Lancet. The study of a million UK women also showed that the common but mistaken belief that happiness and stress directly cause ill health has been fuelled by the confusion of cause and effect by previous studies.
Stentys has announced that patient enrolment in its DESSOLVE III study has been completed. The 1,400-patient randomised clinical trial is comparing the MiStent sirolimus-eluting biodegradable polymer stent with the Xience everolimus-eluting, permanent polymer stent (Abbott Vascular).
CorWave has reported promising early results for its left ventricle assist device (LVAD) system, which has the features of pulsatility and a blood speed close to the physiological pace and can be implanted with minimally invasive surgery. The results were presented at 10th European Mechanical Circulatory Support meeting (EUMS; 2–5 December, Paris, France).
The Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) have published a joint document providing recommendations—for institutions and interested physicians—for the establishment and maintenance of left atrial appendage occlusion programmes performing left atrial appendage closure.
Studies have consistently shown that the vast majority of interventional cardiologists are male—for example, a recent study indicated that only 4.5% of US interventional cardiologists are female.1 Furthermore, Jagsi et al2 recently reported that female cardiologists are paid substantially less than male cardiologists even after adjusting for differences in personal, job, and practice characteristics. This article reviews the steps being taken to ensure that being female is not a barrier to being an interventional cardiologist.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos